The Ensign Group, Inc. (ENSG)
NASDAQ: ENSG · IEX Real-Time Price · USD
125.93
+1.79 (1.44%)
At close: Jul 2, 2024, 4:00 PM
126.25
+0.32 (0.25%)
After-hours: Jul 2, 2024, 7:51 PM EDT
The Ensign Group Revenue
The Ensign Group had revenue of $3.85B in the twelve months ending March 31, 2024, with 20.44% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $1.01B with 13.91% year-over-year growth. In the year 2023, The Ensign Group had annual revenue of $3.73B with 23.27% growth.
Revenue (ttm)
$3.85B
Revenue Growth
+20.44%
P/S Ratio
1.86
Revenue / Employee
$109,141
Employees
35,300
Market Cap
7.17B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 3.73B | 703.89M | 23.27% |
Dec 31, 2022 | 3.03B | 398.01M | 15.15% |
Dec 31, 2021 | 2.63B | 224.87M | 9.36% |
Dec 31, 2020 | 2.40B | 366.07M | 17.98% |
Dec 31, 2019 | 2.04B | 281.92M | 16.07% |
Dec 31, 2018 | 1.75B | 156.28M | 9.78% |
Dec 31, 2017 | 1.60B | -56.54M | -3.42% |
Dec 31, 2016 | 1.65B | 313.04M | 23.33% |
Dec 31, 2015 | 1.34B | 314.42M | 30.60% |
Dec 31, 2014 | 1.03B | 122.85M | 13.58% |
Dec 31, 2013 | 904.56M | 81.40M | 9.89% |
Dec 31, 2012 | 823.16M | 64.88M | 8.56% |
Dec 31, 2011 | 758.28M | 108.75M | 16.74% |
Dec 31, 2010 | 649.53M | 107.53M | 19.84% |
Dec 31, 2009 | 542.00M | 72.63M | 15.47% |
Dec 31, 2008 | 469.37M | 58.05M | 14.11% |
Dec 31, 2007 | 411.32M | 52.74M | 14.71% |
Dec 31, 2006 | 358.57M | 57.72M | 19.19% |
Dec 31, 2005 | 300.85M | 56.31M | 23.03% |
Dec 31, 2004 | 244.54M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Elanco Animal Health | 4.37B |
Bio-Rad Laboratories | 2.61B |
Penumbra | 1.10B |
HealthEquity | 1.04B |
Ionis Pharmaceuticals | 776.62M |
Repligen | 607.45M |
Intra-Cellular Therapies | 513.93M |
Ascendis Pharma | 357.63M |
ENSG News
- 18 days ago - The Ensign Group, Inc. Declares Quarterly Dividend of $0.06 Per Share - GlobeNewsWire
- 4 weeks ago - The Ensign Group Adds Another Skilled Nursing Facility in Colorado - GlobeNewsWire
- 4 weeks ago - The Ensign Group Acquires Skilled Nursing Facility in Arizona - GlobeNewsWire
- 7 weeks ago - Ensign-Bickford Chooses Boomi to Reduce Costs While Improving Productivity, Work-Life Balance, and Customer Satisfaction - Business Wire
- 2 months ago - CareTrust REIT Funds Mortgage Financing with Purchase Option on Tennessee Skilled Nursing Facilities; Reports Reloaded Pipeline of $260 Million and Q1 ATM Activity of $273 Million - Business Wire
- 2 months ago - The Ensign Group Reports First Quarter 2024 Results - GlobeNewsWire
- 2 months ago - The Ensign Group Acquires Long-Term Acute Care Hospital and Skilled Nursing Facility in Utah - GlobeNewsWire
- 2 months ago - The Ensign Group Adds Skilled Nursing Facility in Texas - GlobeNewsWire